GlassScriptPhysician profile
Christopher C Hasty
NPI 1730173246
$3,815.18
in general payments reported to CMS, 2019-2025
9 companies · $295 in 2025
The $295 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $663 · 2021: $1,000 · 2022: $485 · 2023: $233 · 2024: $1,140 · 2025: $295.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,062 · Travel and Lodging: $606.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,061.63 |
| Travel and Lodging | $605.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tricoast Surgical Solutions LLC | $1,541.50 | 2022-2025 | |
| Zimmer Biomet Holdings, INC. | $1,018.57 | 2019-2025 | Persona, Osseoti Reconstructive System |
| Southtech Orthopedics | $1,000.00 | 2021 | |
| Lifenet Health | $120.47 | 2024 | Allograft Vmis Delivery System |
| Innovation Technologies INC | $45.61 | 2024 | Irrisept |
| Medtronic, INC. | $39.70 | 2022 | |
| Boston Scientific Corporation | $18.28 | 2022 | |
| Avanos Medical | $16.74 | 2025 | |
| Masimo Corporation | $14.31 | 2024 | Sedline |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Hasty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.